Haifeng Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Haifeng Ma has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Bin Liu
Department of Neurosurgery, Qinghai Provincial People's Hospital, Xining, Qinghai, China
1 shared publication - Guofeng Li
Department of Neurosurgery, Qinghai Provincial People’s Hospital, Xining, Qinghai 810007, China
1 shared publication - Kai Zhang
Department of Neurosurgery, Shaanxi Provincial People’s Hospital, Xi’an, China
1 shared publication - Mingfei Yang
Department of Neurosurgery, Qinghai Provincial People's Hospital
1 shared publication - Qiang Zhang
Qinghai Provincial People's Hospital. Xining, Qinghai, 810007, China; Qinghai Clinical Research Center for High Altitude Diseases, Xining, Qinghai, 810007, China
1 shared publication - Ting Sun
Neurosurgery and Brain and Nerve Research Laboratory, First Affiliated Hospital of Soochow University, Suzhou, China
1 shared publication
Latest Publications
- Open Access
Glioma Stem Cells Upregulate CD39 Expression to Escape Immune Response through SOX2 Modulation
Ectonucleotidase CD39 hydrolyzing extracellular ATP (eATP) functions as a key modulator of immune response in the tumor microenvironment, yet the role of CD39 in contributing tumor stem cells in a more immunosuppressive microenvironment remains elusive. Here we report that the upregulation of CD39 is crucial for the decrease of extracellular ATP concentration around glioma stem cells (GSCs) to maintain an immunosuppressive microenvironment. Adriamycin (ADM) is able to promote the release of ATP, which recruits dendritic cells (DCs) to phagocytose GSCs. CD39 inhibition further increased extracellular ATP concentrations following ADM treatment and DCs phagocytosis. In addition, GSCs upregulated CD39 expression by SOX2-binding CD39 promotor. In mouse tumor models, the combination of ADM and CD39 blockade increased immune cell infiltration and reduced tumor size. These findings suggest that GSCs upregulate CD39 expression by their biological characteristics to maintain an immunosuppressive microenvironment, and CD39 inhibition supplies a favorable tumor microenvironment (TME) for immunotherapeutic intervention and enhances the immune response induced by chemotherapy.
Open AccessGlioma Stem Cells Upregulate CD39 Expression to Escape Immune Response through SOX2 Modulation
Ectonucleotidase CD39 hydrolyzing extracellular ATP (eATP) functions as a key modulator of immune response in the tumor microenvironment, yet the role of CD39 in contributing tumor stem cells in a more immunosuppressive microenvironment remains elusive. Here we report that the upregulation of CD39 is crucial for the decrease of extracellular ATP concentration around glioma stem cells (GSCs) to maintain an immunosuppressive microenvironment. Adriamycin (ADM) is able to promote the release of ATP, which recruits dendritic cells (DCs) to phagocytose GSCs. CD39 inhibition further increased extracellular ATP concentrations following ADM treatment and DCs phagocytosis. In addition, GSCs upregulated CD39 expression by SOX2-binding CD39 promotor. In mouse tumor models, the combination of ADM and CD39 blockade increased immune cell infiltration and reduced tumor size. These findings suggest that GSCs upregulate CD39 expression by their biological characteristics to maintain an immunosuppressive microenvironment, and CD39 inhibition supplies a favorable tumor microenvironment (TME) for immunotherapeutic intervention and enhances the immune response induced by chemotherapy.